RYTMLLYmerger acquisitionRythm Pharmaceuticals gains on report Eli Lilly made $150/share offer with CVRRhythm Pharmaceuticals shares rose 3.6% following reports that Eli Lilly submitted a rival acquisition bid.Seeking AlphaNov 17, 2026, 5:22 PM UTCPositiveRead AI summary View original